Bri-Chem Corp.
Bri-Chem Corp. (BRY.TO) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Bri-Chem Corp. (BRY.TO), covering cash flow, earnings, and balance sheets.
Bri-Chem Corp. (BRY.TO) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Bri-Chem Corp. BRY.TO financial performance.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $19.91M | $20.62M | $21.98M | $19.11M |
Cost of Revenue | $16.47M | $17.91M | $18.16M | $17.20M |
Gross Profit | $3.44M | $2.71M | $3.82M | $1.90M |
Gross Profit Ratio | $0.17 | $0.13 | $0.17 | $0.10 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $2.99M | $2.02M | $3.28M | $1.28M |
Operating Expenses | $3.32M | $2.33M | $3.58M | $1.28M |
Total Costs & Expenses | $19.79M | $20.24M | $21.74M | $18.49M |
Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
Interest Expense | $725863.00 | $703644.00 | $787982.00 | $896945.00 |
Depreciation & Amortization | $327500.00 | $313307.00 | $307310.00 | $325367.00 |
EBITDA | $466618.00 | -$1.17M | $587164.00 | $706827.00 |
EBITDA Ratio | $0.02 | -$0.06 | $0.03 | $0.04 |
Operating Income | $121088.00 | $380452.00 | $233835.00 | $620160.00 |
Operating Income Ratio | $0.006 | $0.02 | $0.01 | $0.03 |
Other Income/Expenses (Net) | -$707833.00 | -$2.57M | -$741963.00 | -$1.14M |
Income Before Tax | -$586745.00 | -$2.19M | -$508128.00 | -$515481.00 |
Income Before Tax Ratio | -$0.03 | -$0.11 | -$0.02 | -$0.03 |
Income Tax Expense | -$174965.00 | -$602374.00 | -$239301.00 | -$27680.00 |
Net Income | -$411780.00 | -$1.59M | -$268827.00 | -$487801.00 |
Net Income Ratio | -$0.02 | -$0.08 | -$0.01 | -$0.03 |
EPS | -$0.02 | -$0.06 | -$0.01 | -$0.02 |
Diluted EPS | -$0.02 | -$0.06 | -$0.01 | -$0.02 |
Weighted Avg Shares Outstanding | $26.43M | $26.43M | $26.88M | $26.43M |
Weighted Avg Shares Outstanding (Diluted) | $26.53M | $26.43M | $26.88M | $26.43M |
Over the past four quarters, Bri-Chem Corp. demonstrated steady revenue growth, increasing from $19.11M in Q2 2024 to $19.91M in Q1 2025. Operating income reached $121088.00 in Q1 2025, maintaining a consistent 1% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $466618.00, reflecting operational efficiency. Net income rose to -$411780.00, with EPS at -$0.02. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan